| Milan, September 2007 |
MEDIOLAST S.P.A. joined INFA Group
We are pleased to announce that, on 25th September 2007 MEDIOLAST S.P.A. joined INFA Group.
|
| Milan, September 2007 |
INFA S.P.A. SIGNS DISTRIBUTION AGREEMENT WITH HEMMO PHARMA (CREEK INSULATIONS)
We are pleased to announce that on August 1, INFA S.p.A. and HEMMO PHARMA (CREEK INSULATIONS)( www.hemmopharma.com), the largest Indian producer of Oxytocin, with more than 35 years of product development a
|
| Milan, June 2007 |
INFA S.P.A. SIGNS AGENCY AGREEMENT WITH FOUGERA US
We are pleased to announce that on June 27, INFA S.p.A. and FOUGERA (www.fougera.com) executed an agreement for the distribution of some products line developed by FOUGERA on some selected European markets.
|
| Milan, November 2006 |
Labochim boosts its offering
Labochim, the active pharmaceutical ingredient (API) manufacturing arm of Italy's INFA group has celebrated its 40th anniversary by adding the alcohol-withdrawal agent acamprosate, the anti-infective atovaquone, and the epilepsy pain drug pregabalin
|
| Milan, June 2006 - breaking news |
INFA Group executed an investment agreement
On 21st June 2006 INFA Group executed an investment agreement with one of the major and most qualified Italian Private Equity Funds – Investitori Associati – who became the major shareholder of the group.
|
|
 |
